e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aura Biosciences
Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
November 10, 2022
From
Aura Biosciences
Via
Business Wire
Tickers
AURA
Aura Biosciences Presents Final Phase 1b/2 Data for its first Virus-Like Drug Conjugate, AU-011, in Patients with Choroidal Melanoma at the American Academy of Ophthalmology 2021 Annual Meeting
November 15, 2021
From
Aura Biosciences
Via
Business Wire
Tickers
AURA
Aura Biosciences Presents Interim Phase 2 Safety Data Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma at the ASRS 2021 Annual Meeting
October 11, 2021
From
Aura Biosciences
Via
Business Wire
Aura Biosciences Expands Executive Leadership Team and Board of Directors
September 29, 2021
From
Aura Biosciences
Via
Business Wire
Aura Biosciences Assembles New Bladder Cancer Focused Scientific Advisory Board
June 17, 2021
From
Aura Biosciences
Via
Business Wire
Aura Biosciences Appoints Sapna Srivastava, Ph.D., to its Board of Directors
June 08, 2021
From
Aura Biosciences
Via
Business Wire
Aura Biosciences Presents New Preclinical AU-011 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting
May 03, 2021
From
Aura Biosciences
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert